NCT01509924

Brief Summary

The purpose of this study is to determine whether Physical Activation on Prescription can help patients with TIA to become more physically active. One group will receives Physical Activation on Prescription (PaP)and the other group will receives usual care. And to identify if persons with TIA presents with cognitive impairments.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

June 7, 2011

Completed
7 months until next milestone

First Posted

Study publicly available on registry

January 13, 2012

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
Last Updated

September 16, 2014

Status Verified

September 1, 2014

Enrollment Period

4.9 years

First QC Date

June 7, 2011

Last Update Submit

September 15, 2014

Conditions

Keywords

Walking capacityMental FatigueQuality of LifeCognitionMotor activityExercise

Outcome Measures

Primary Outcomes (1)

  • Change in Physical activity over time

    Physical activity measured with accelerometer (Time frame: Baseline, 3, 6, and 12 month).

    at discharge from hospital, 3, 6 and 12 month after the event

Secondary Outcomes (7)

  • Change in Cognition and Mental Fatigue

    All measures at baseline 3, 6 and 12 month after the event

  • Change in 6 MWT

    3, 6 and 12 months

  • Change in self reported stages of change

    3, 6, 12 months

  • Change from baseline in systolic blood pressure at 12 months

    3, 6, 12 months

  • BMI

    12 months

  • +2 more secondary outcomes

Study Arms (4)

Physical activity on Prescription (PaP)

EXPERIMENTAL

Intervention group receives a PaP for 12 month.

Other: Physical activation on Prescription

Control Group

NO INTERVENTION

The control group has the same monitoring as the experimental group but receives no PaP.

Cognitiv function in patients with TIA

NO INTERVENTION

Before discharged from hospital cognitive function is assessed. At the first visit the patients fill in a self assessment questionnaire for mental fatigue. If impaired at the previous assessment cognitive function will be assessed at 3, 6 and 12 month.

Controlgroup Cognitive function

NO INTERVENTION

In order to determine whether hospitalization in itself is associated with transient impaired cognition, a comparison group will be included. The comparison group will consist of patients with angina pectoris consecutively admitted to the Norrtälje Hospital. The patients with angina pectoris will be age and sex matched with the patients with TIA and assessed for cognitive function when their angina symptoms have subsided.

Interventions

The advice on physical activity is patient oriented and based on FYSS (FYSS is a information bank that summarizes the up-to-date scientific knowledge on how to prevent and treat various diseases and conditions using physical activity). An individual prescription on physical activity is issued. The prescription form reminds of an ordinary drug prescription and provides specified types of physical activities including intensity, frequency and duration of the respective activities. The prescribed physical activity could be either self-monitored or organized by public physical activity organizations.

Also known as: PaP
Physical activity on Prescription (PaP)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Understand Swedish language (also in and writing), living in Norrtälje community,
  • To participate in the assessment of cognitive function: no known cognitive impairments before the TIA event and history of stroke.

You may not qualify if:

  • Presence of contraindications to exercise, and no history of stroke

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tiohundra

Norrtälje, Stockholms Läns Landsting, 76192, Sweden

Location

MeSH Terms

Conditions

Ischemic Attack, TransientMental FatigueMotor Activity

Condition Hierarchy (Ancestors)

Brain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesFatigueSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Study Officials

  • Disa Sommerfeld

    Karolinska Institutet

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 7, 2011

First Posted

January 13, 2012

Study Start

May 1, 2010

Primary Completion

April 1, 2015

Study Completion

July 1, 2015

Last Updated

September 16, 2014

Record last verified: 2014-09

Locations